Oligonucleotide-Based Therapeutics Summit

December 9-11, 2025 | Boston, MA

Conference website: https://oligonucleotide-based-therapeutics.com

 
Why Attend the Oligonucleotide-based Therapeutics Summit?
 
The Oligonucleotide-based Therapeutics Summit is the only industry-focused meeting solely dedicated to advancing oligonucleotides from discovery through late-stage development.
Driven by accelerating clinical progress and breakthroughs in chemical design and targeted delivery, oligonucleotides are redefining what’s possible,  rapidly advancing as a leading therapeutic class for both proven and once “undruggable” targets.
 
Join 60+ biotech and pharma experts from Secarna, Genentech, Avidity Bioscience, Dyne Therapeutics, Biogen, Novo Nordisk, Stoke Therapeutics, and more to explore how the latest breakthroughs in chemistry and delivery are enabling safer, more targeted, and more effective therapies.
 
As the momentum accelerates, this is your opportunity to position yourself at the forefront of the oligonucleotide revolution, connect with scientific leaders shaping the field, and gain the insights you need to drive your programs forward.
 
Explore the Full Event Guide
* 60+ Attendees
* 16+ World-class Speakers
* 2 Hands-on Workshops
* Unrivalled networking opportunities
* Insights spanning multiple therapeutic areas
 
Attending Companies Include:
 

 
Contact us
Lily Morris
Tel: +44 (0)20 3141 8700
Email: lily.morris@hansonwade.com